Islet Cell Carcinoma (Insulinoma) - Pipeline Review, H2 2012 - New Market Report Now Available
Global Markets Direct's, 'Islet Cell Carcinoma (Insulinoma) - Pipeline Review, H2 2012', provides an overview of the indication's therapeutic pipeline. This report provides information on the therapeutic development for Islet Cell Carcinoma (Insulinoma), complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Islet Cell Carcinoma (Insulinoma). Islet Cell Carcinoma (Insulinoma) - Pipeline Review, Half Year is built using data and information sourced from Global Markets Direct's...
View full press release